BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 2119660)

  • 1. GTPase-inhibiting mutations in the alpha subunit of Gs.
    Masters SB; Landis CA; Bourne HR
    Adv Second Messenger Phosphoprotein Res; 1990; 24():70-5. PubMed ID: 2119660
    [No Abstract]   [Full Text] [Related]  

  • 2. GTP-binding proteins as oncogenes in human tumors.
    McCormick F
    Environ Health Perspect; 1991 Jun; 93():17-8. PubMed ID: 1773789
    [No Abstract]   [Full Text] [Related]  

  • 3. GTPase-inhibiting mutations activate the alpha-chain of Gs in human tumours.
    Vallar L
    Biochem Soc Symp; 1990; 56():165-70. PubMed ID: 2124121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A guide to low molecular weight GTPases.
    Sanders DA
    Cell Growth Differ; 1990 May; 1(5):251-8. PubMed ID: 2150754
    [No Abstract]   [Full Text] [Related]  

  • 5. Linear free energy relationships in the intrinsic and GTPase activating protein-stimulated guanosine 5'-triphosphate hydrolysis of p21ras.
    Schweins T; Geyer M; Kalbitzer HR; Wittinghofer A; Warshel A
    Biochemistry; 1996 Nov; 35(45):14225-31. PubMed ID: 8916907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulators and effectors of ras proteins.
    Bollag G; McCormick F
    Annu Rev Cell Biol; 1991; 7():601-32. PubMed ID: 1667084
    [No Abstract]   [Full Text] [Related]  

  • 7. The mechanism of Ras GTPase activation by neurofibromin.
    Phillips RA; Hunter JL; Eccleston JF; Webb MR
    Biochemistry; 2003 Apr; 42(13):3956-65. PubMed ID: 12667087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The ras gene family.
    Lowy DR; Willumsen BM
    Cancer Surv; 1986; 5(2):275-89. PubMed ID: 3096566
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hydrolysis of GTP by the alpha-chain of Gs and other GTP binding proteins.
    Bourne HR; Landis CA; Masters SB
    Proteins; 1989; 6(3):222-30. PubMed ID: 2516316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversion and rereversion in ras-transformed cells.
    Marshall CJ
    Immunol Ser; 1990; 51():89-106. PubMed ID: 2128917
    [No Abstract]   [Full Text] [Related]  

  • 11. GTPase inhibiting mutations activate the alpha chain of Gs and stimulate adenylyl cyclase in human pituitary tumours.
    Landis CA; Masters SB; Spada A; Pace AM; Bourne HR; Vallar L
    Nature; 1989 Aug; 340(6236):692-6. PubMed ID: 2549426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regional homology in GTP-binding proto-oncogene products and elongation factors.
    Halliday KR
    J Cyclic Nucleotide Protein Phosphor Res; 1983-1984; 9(6):435-48. PubMed ID: 6396323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three-dimensional structure of p21 in the active conformation and analysis of an oncogenic mutant.
    Wittinghofer F; Krengel U; John J; Kabsch W; Pai EF
    Environ Health Perspect; 1991 Jun; 93():11-5. PubMed ID: 1773783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A yeast GTPase-activating protein that interacts specifically with a member of the Ypt/Rab family.
    Strom M; Vollmer P; Tan TJ; Gallwitz D
    Nature; 1993 Feb; 361(6414):736-9. PubMed ID: 8441469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. G protein amino-terminal alpha i2/alpha s chimeras reveal amino acids important in regulating alpha s activity.
    Russell M; Johnson GL
    Mol Pharmacol; 1993 Aug; 44(2):255-63. PubMed ID: 8394989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. What is the role of the helical domain of Gsalpha in the GTPase reaction?
    Shnerb T; Lin N; Shurki A
    Biochemistry; 2007 Sep; 46(38):10875-85. PubMed ID: 17727271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative biochemical properties of normal and activated human ras p21 protein.
    McGrath JP; Capon DJ; Goeddel DV; Levinson AD
    Nature; 1984 Aug 23-29; 310(5979):644-9. PubMed ID: 6147754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of the GTP-binding/GTPase cycle of Cdc42Hs using extrinsic reporter group fluorescence.
    Nomanbhoy TK; Leonard DA; Manor D; Cerione RA
    Biochemistry; 1996 Apr; 35(14):4602-8. PubMed ID: 8605211
    [TBL] [Abstract][Full Text] [Related]  

  • 19. trans-Dominant suppressor mutations of the H-ras oncogene.
    Ogiso Y; Gutierrez L; Wrathall LS; Lu YY; Blair DG; Clanton DJ; Hwang YW; Shih TY
    Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure of the guanine-nucleotide-binding domain of the Ha-ras oncogene product p21 in the triphosphate conformation.
    Pai EF; Kabsch W; Krengel U; Holmes KC; John J; Wittinghofer A
    Nature; 1989 Sep; 341(6239):209-14. PubMed ID: 2476675
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.